Are you Dr. Wald?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 8 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
300 Longwood Ave
Boston, MA 02115Phone+1 617-355-6793
Summary
- Dr. Rachel Wald, MD is a pediatric cardiologist in Boston, Massachusetts. She is currently licensed to practice medicine in Massachusetts.
Education & Training
Boston Children’s Hospital/Boston Medical CenterFellowship, Pediatric Cardiology, 2004 - 2005
University of Toronto Faculty of MedicineClass of 1998
Certifications & Licensure
MA State Medical License 2005 - 2025- American Board of Pediatrics Pediatric Cardiology
Clinical Trials
- Feasibility and Efficacy of Portable Non-invasive Negative Pressure Ventilation in Fontan Patients Start of enrollment: 2017 Nov 17
Publications & Presentations
PubMed
- 88 citationsRefining the assessment of pulmonary regurgitation in adults after tetralogy of Fallot repair: should we be measuring regurgitant fraction or regurgitant volume?Rachel M. Wald, Andrew N. Redington, Andre Pereira, Yves Provost, Narinder Paul
European Heart Journal. 2008-09-10 - 44 citationsMagnetic resonance assessment of pulmonary (QP) to systemic (QS) flows using 4D phase-contrast imaging: pilot study comparison with standard through-plane 2D phase-con...Kate Hanneman, Milani Sivagnanam, Elsie T. Nguyen, Rachel M. Wald, Andreas Greiser
Academic Radiology. 2014-08-01 - 330 citationsContemporary predictors of death and sustained ventricular tachycardia in patients with repaired tetralogy of Fallot enrolled in the INDICATOR cohortAnne Marie Valente, Kimberlee Gauvreau, Gabriele Egidy Assenza, Sonya V. Babu-Narayan, Jenna Schreier
Heart. 2014-02-01
Authored Content
- Evolving Therapies in Fontan FailureJuly 2020
Press Mentions
First Global Study to Examine Therapy for Patients with Single-Ventricle Cardiac Defect BeginsApril 11th, 2018
